Erin Jou

466 total citations
14 papers, 332 citations indexed

About

Erin Jou is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Erin Jou has authored 14 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in Erin Jou's work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Erin Jou is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Erin Jou collaborates with scholars based in United States, China and Hong Kong. Erin Jou's co-authors include Daniel M. Knowles, Andrea Cerutti, Amy Chadburn, Elaine J. Schattner, Bing He, Lakshmi Rajdev, Andreas Kaubisch, Justin Tang, Sanjay Goel and Abdissa Negassa and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Erin Jou

13 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erin Jou United States	5	179	89	89	65	59	14	332
Zsolt Zoltán Fülöp Romania	9	142 0.8×	121 1.4×	87 1.0×	103 1.6×	41 0.7×	17	326
Valentina Griggio Italy	10	208 1.2×	75 0.8×	144 1.6×	90 1.4×	34 0.6×	18	362
Antonella Bresin Italy	11	170 0.9×	131 1.5×	116 1.3×	110 1.7×	56 0.9×	19	408
Paulina Lange United States	10	156 0.9×	73 0.8×	179 2.0×	50 0.8×	88 1.5×	15	417
Chuen‐Miin Leu Taiwan	8	169 0.9×	158 1.8×	69 0.8×	35 0.5×	52 0.9×	12	374
Hsu-Ping Kuo United States	8	150 0.8×	174 2.0×	186 2.1×	123 1.9×	31 0.5×	10	409
Jenny Bulgarelli Italy	10	167 0.9×	153 1.7×	98 1.1×	78 1.2×	44 0.7×	20	389
Laura J. Gibbons United Kingdom	10	204 1.1×	85 1.0×	75 0.8×	47 0.7×	67 1.1×	10	492
Noelia Purroy Spain	10	123 0.7×	113 1.3×	88 1.0×	136 2.1×	28 0.5×	18	334
Rebecca Kan United States	6	96 0.5×	75 0.8×	193 2.2×	41 0.6×	53 0.9×	7	322

Countries citing papers authored by Erin Jou

Since Specialization

Citations

This map shows the geographic impact of Erin Jou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Jou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Jou more than expected).

Fields of papers citing papers by Erin Jou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Jou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Jou. The network helps show where Erin Jou may publish in the future.

Co-authorship network of co-authors of Erin Jou

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Jou. A scholar is included among the top collaborators of Erin Jou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Jou. Erin Jou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Thakur, Richa, Erin Jou, Douglas E. Gladstone, et al.. (2024). Less is more: An analysis of venetoclax and hypomethylating agent post-induction treatment modifications in AML. Leukemia Research. 143. 107545–107545. 2 indexed citations

Sekeres, Mikkael A., Pau Montesinos, Jan Novák, et al.. (2023). Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial. Leukemia. 37(10). 2017–2026. 15 indexed citations

Thakur, Richa, et al.. (2023). Outcomes and Hospital Resource Utilization Associated with Decreased Ven Exposure in Acute Myeloid Leukemia Patients: A Real-World Retrospective Review. Blood. 142(Supplement 1). 4268–4268. 1 indexed citations

Zhang, Xinmin, et al.. (2022). CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis. Leukemia Research Reports. 17. 100334–100334. 1 indexed citations

Jou, Erin, et al.. (2022). Evaluation of the efficacy of ursodiol for prevention of hepatotoxicity in patients receiving gemtuzumab ozogamicin and inotuzumab ozogamicin. Journal of Oncology Pharmacy Practice. 29(4). 840–845. 2 indexed citations

Jou, Erin, Andreas Kaubisch, Lakshmi Rajdev, et al.. (2019). The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer. Journal of Gastrointestinal Cancer. 51(3). 868–876. 17 indexed citations

Jou, Erin & Lakshmi Rajdev. (2016). Current and emerging therapies in unresectable and recurrent gastric cancer. World Journal of Gastroenterology. 22(20). 4812–4812. 40 indexed citations

Jou, Erin, Diwakar Mohan, Uriel R. Felsen, et al.. (2016). Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies. Annals of Hematology. 95(4). 575–580. 4 indexed citations

Jou, Erin, et al.. (2016). Analysis of survival outcomes among ethnic minorities with pancreatic cancer treated at an urban academic cancer center.. Journal of Clinical Oncology. 34(15_suppl). e15734–e15734. 3 indexed citations

10.

Jou, Erin, Diwakar Mohan, Uriel R. Felsen, et al.. (2015). Retrospective study of the prevalence and progression of monoclonal gammopathy in HIV positive versus HIV negative patients. Hematological Oncology. 35(1). 64–68. 4 indexed citations

11.

Jou, Erin, Diwakar Mohan, Uriel R. Felsen, et al.. (2014). Retrospective Study of the Incidence and Risk Factors for Hematological Malignancies in Patients with Hepatitis B Virus Infection. Blood. 124(21). 5403–5403. 1 indexed citations

12.

Jou, Erin, et al.. (2013). The Incidence and Risk Factors For Hematological Malignancies and Premalignant Hematological Disorders In HIV. Blood. 122(21). 4304–4304.

13.

He, Bing, Amy Chadburn, Erin Jou, et al.. (2004). Lymphoma B Cells Evade Apoptosis through the TNF Family Members BAFF/BLyS and APRIL. The Journal of Immunology. 172(5). 3268–3279. 230 indexed citations

14.

He, Bing, Amy Chadburn, Erin Jou, et al.. (2004). Lymphoma B Cells Evade Apoptosis through the TNF Family Members BAFF/BLyS and APRIL.. The Journal of Immunology. 172(8). 5128–5128. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact